Cargando…
A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human β-Cell Replication and Survival as well as GABA's Ability to Inhibit Inflammatory T Cells
A major goal of T1D research is to develop new approaches to increase β-cell mass and control autoreactive T cell responses. GABA(A)-receptors (GABA(A)-Rs) are promising drug targets in both those regards due to their abilities to promote β-cell replication and survival, as well as inhibit autoreact...
Autores principales: | Tian, Jide, Dang, Hoa, Karashchuk, Nataliya, Xu, Irvin, Kaufman, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413367/ https://www.ncbi.nlm.nih.gov/pubmed/30937314 http://dx.doi.org/10.1155/2019/5783545 |
Ejemplares similares
-
Clinically applicable GABA receptor positive allosteric modulators promote ß-cell replication
por: Tian, Jide, et al.
Publicado: (2017) -
Combining Antigen-Based Therapy with GABA Treatment Synergistically Prolongs Survival of Transplanted ß-Cells in Diabetic NOD Mice
por: Tian, Jide, et al.
Publicado: (2011) -
Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
por: Tian, Jide, et al.
Publicado: (2014) -
The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19
por: Tian, Jide, et al.
Publicado: (2023) -
Homotaurine, a safe blood-brain barrier permeable GABA(A)-R-specific agonist, ameliorates disease in mouse models of multiple sclerosis
por: Tian, Jide, et al.
Publicado: (2018)